Hydrops fetalis
Hydrops fetalis | |
---|---|
An ultrasound showing a fetus with hydrops fetalis | |
Specialty | Obstetrics and gynaecology, hematology, immunology |
Hydrops fetalis or hydrops foetalis is a condition in the fetus characterized by an accumulation of fluid, or edema, in at least two fetal compartments.[1][2] By comparison, hydrops allantois or hydrops amnion is an accumulation of excessive fluid in the allantoic or amniotic space, respectively.[3]
Signs and symptoms
Locations can include the
Causes
Hydrops fetalis usually stems from fetal
Immune pathophysiology
Erythroblastosis fetalis, also known as Rh disease, is the only immune cause of hydrops fetalis. Rh disease is a hemolytic disease of newborns. Pregnant mothers do not always have the same blood type as their child. During birth or throughout the pregnancy, the mother may be exposed to the infant's blood. In the event of a pregnancy where the fetus has the Rh-D blood antigen and the mother does not, the mother's immune system will respond to the red blood cells as foreign and create antibodies against the Rh-D antigen on the fetal blood cells. Rh disease develops in the event of a second pregnancy where the mother's immune system launches an attack, via IgG, against the infant's Rh-D positive blood cells. The immune response results in hemolysis of fetal red blood cells causing severe anemia.[citation needed]
Hemolysis caused by the Rh incompatibility, causes extramedullary hematopoiesis in the fetal liver and bone marrow.[6] The push to make more erythroblasts to help compensate with the hemolysis over works the liver causing hepatomegaly. The resulting liver dysfunction decreases albumin output which in turn decreases oncotic pressure. Consequentially, the decrease in pressure results in overall peripheral edema and ascites.[citation needed]
Rh disease is currently an uncommon cause of immune-mediated hydrops fetalis. Due to preventative methods developed in the 1970s, the incidence of Rh disease has markedly declined. Rh disease can be prevented by administration of anti-D IgG (
Non-immune pathophysiology
Severe anemia leads to hyperdynamic circulation, which means high-output cardiac failure causes the blood to circulate rapidly. The excessive pumping of blood causes the left side of the heart to fail leading to pulmonary edema. The build up of fluid in the lungs increases the pressure in the lungs leading to vasoconstriction. The coupled vasoconstriction and pulmonary hypertension causes the right side of the heart to fail which in turn, increases the venous hydrostatic pressure in the body. The summation of these effects ultimately leads to peripheral edema and ascites. All in all, the left side failure of the heart will lead to pulmonary edema whereas right side failure will lead to peripheral edema and ascites. The non-immune form of hydrops fetalis has many causes including:[7][8]
- Iron deficiency anemia
- Paroxysmal supraventricular tachycardia resulting in heart failure
- Deficiency of the enzyme mucopolysaccharidosis type VII.
- Congenital disorders of glycosylation
- Parvovirus B19 (fifth disease) infection of the pregnant woman (most common cause)
- Cytomegalovirus in mother
- congenital cystic adenomatoid malformation)
- Maternal syphilis and maternal diabetes mellitus
- Alpha-thalassemia can also cause hydrops fetalis when all four of the genetic loci for α globin are deleted or affected by mutation. This is termed Hb Barts (consists of y-4 tetramers).
- Uncommonly, Gaucher diseasetype 2 can present with hydrops fetalis.
- Turner syndrome
- Tumors,[9] the most common type of fetal tumor being teratoma, particularly a sacrococcygeal teratoma.
- Twin-twin transfusion syndrome (TTTS) in pregnancies in which twins share a single placenta(hydrops affects the recipient twin)
- Twin anemia-polycythemia sequence (TAPS)
- Twin reversed arterial perfusion sequence (TRAPS)
- Maternal hyperthyroidism
- Fetal cardiac defects and skeletal defects
- Noonan syndrome
- preeclampsia, edema and hypertension
- Down syndrome
Diagnosis
Hydrops fetalis can be diagnosed and monitored by ultrasound scans.[1] An official diagnosis is made by identifying excess serous fluid in at least one space (ascites, pleural effusion, of pericardial effusion) accompanied by skin edema (greater than 5 mm thick). A diagnosis can also be made by identifying excess serous fluid in two potential spaces without accompanying edema. Prenatal ultrasound scanning enables early recognition of hydrops fetalis and has been enhanced with the introduction of MCA Doppler.[7]
Treatment
The treatment depends on the cause and stage of the pregnancy.[7]
- Severely
- Therapy for Cardiac tachyarrhythmia, supraventricular tachycardia, atrial flutter, or atrial fibrillation etiologies are maternal transplacental administration of antiarrhythmic medication(s). This type of treatment is recommended unless the fetus is close to term.[12]
- Therapy for Fetal anemia caused by a parvovirus infection or fetomaternal hemorrhage is fetal blood sampling followed by intrauterine transfusion. This treatment at an advanced gestational age poses risks and should not be performed if the risks associated with delivery are considered to be less than those associated with the procedure.[13]
- Fetal hydrothorax, chylothorax, or large pleural effusion associated with bronchopulmonary sequestration should be treated using a Fetal needle drainage of effusion or placement of thoracoamniotic shunt. This procedure can be performed prior to delivery if gestational age is advanced.[14]
- Hydrops Fetalis resulting from fetal CPAM can be treated using either a fetal needle drainage of effusion or placement of thoracoamniotic shunt or a maternal administration of corticosteroids, betamethasone 12.5 mg IM q24 h × 2 doses or dexamethasone 6.25 mg IM q12 h × 4 doses.[15]
- Therapy for hydrops fetalis derived from TTTS or TAPS requires laser ablation of placental anastomoses or selective termination.[16]
- Therapy for hydrops fetalis derived from TRAPS requires percutaneous radio frequency ablation.[17]
See also
References
- ^ PMID 33085361.
- ^ Hamdan AH, Sheftel DN, Rosenkrantz T. Windle ML, Pramanik AK, Nimavat DJ (eds.). "Pediatric Hydrops Fetalis". eMedicine Pediatrics: Cardiac Disease and Critical Care Medicine. Retrieved 2010-02-11.
- ISBN 9780702021305. Retrieved 2010-02-11.
- PMID 26889318.
- PMID 18075961.
- PMID 23715539.
- ^ PMID 25557883.
- S2CID 3601812.
- PMID 18075961.
- PMID 20008180.
- PMID 25598092.
- PMID 24763516.
- PMID 2536885.
- S2CID 206542529.
- S2CID 24586927.
- S2CID 78687065.
- S2CID 12699823.